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Myeloid transformation by MLL-ENL depends strictly
on C/EBP
Radoslaw Wesolowski1,*, Elisabeth Kowenz-Leutz1,*, Karin Zimmermann1,†, Dorothea Dörr1,†, Maria Hofstätter1,†,
Robert K Slany2, Alexander Mildner1 , Achim Leutz1,3
Chromosomal rearrangements of the mixed-lineage leuke-
mia gene MLL1 are the hallmark of infant acute leukemia. The
granulocyte-macrophage progenitor state forms the epigenetic
basis for myelomonocytic leukemia stemness and transformation
by MLL-type oncoproteins. Previously, it was shown that the
establishment of murine myelomonocytic MLL-ENL transforma-
tion, but not its maintenance, depends on the transcription factor
C/EBPα, suggesting an epigenetic hit-and-run mechanism of MLL-
driven oncogenesis. Here, we demonstrate that compound de-
letion of Cebpa/Cebpb almost entirely abrogated the growth and
survival of MLL-ENL–transformed cells. Rare, slow-growing, and
apoptosis-proneMLL-ENL–transformed escapees were recovered
from compound Cebpa/Cebpb deletions. The escapees were
uniformly characterized by high expression of the resident Cebpe
gene, suggesting inferior functional compensation of C/EBPα/C/
EBPβ deficiency by C/EBPε. Complementation was augmented by
ectopic C/EBPβ expression and downstream activation of IGF1
that enhanced growth. Cebpe gene inactivation was accomplished
only in the presence of complementing C/EBPβ, but not in its
absence, confirming the Cebpe dependency of the Cebpa/Cebpb
double knockouts. Our data show that MLL-transformed myeloid
cells are dependent on C/EBPs during the initiation and main-
tenance of transformation.
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Introduction
Mixed-lineage leukemia (MLL) represents an aggressive pediatric
cancer of the blood, with features of acute lymphoblastic leukemia
and acute myeloid leukemia (AML). Chromosomal translocations at
11q23 are predominant in MLL and fuse the N-terminal part of the
Trithorax-like MLL1/KMT2A methyltransferase to multiple partner
proteins (Shilatifard, 2012; Slany, 2016). MLL-induced AML may
originate from hematopoietic stem cells (HSCs) and/or an early
progenitor state and involve the establishment of leukemic stem
cells (LSCs) that maintain lineage plasticity and an intermediate
lymphoid–myeloid immunophenotype (Daigle et al, 2011; Goardon
et al, 2011; Chen et al, 2013; Krivtsov et al, 2013). Despite recent
advances in understanding the molecular mechanism of the dis-
ease, therapy of MLL translocation-induced leukemia remains a
clinical challenge.
The prevalent leukemic MLL translocations entail genes encoding
components of the super elongation complex, including ENL,
AF9, and AF4. Both MLL-ENL and MLL-AF4 represent potent fu-
sion oncoproteins that experimentally transform murine bone
marrow cells in vitro (Smith et al, 2011). Mechanistically, MLL fusion
oncoproteins stimulate the expression of target genes, including
critical genes of the HOXA cluster, by co-recruiting the DOT1L
complex and by promoting DNA polymerase II pause release and
the elongation phase of gene transcription (Okada et al, 2005;
Krivtsov & Armstrong, 2007; Krivtsov et al, 2013). Deregulated ex-
pression of the MLL target genes Hoxa9 and Meis1 partially recapit-
ulate leukemogenic self-renewal and eventually cause experimental
leukemogenesis (Collins & Hess, 2016b).
C/EBP (CCAAT enhancer–binding protein) family members are
transcription factors that may function as activators and re-
pressors depending on the cellular and molecular context and
the expression status of the C/EBP protein isoforms (Zahnow,
2002; Nerlov, 2004; Johnson, 2005). C/EBPα, a master regulator of
granulocyte-macrophage progenitor (GMP) biology, is also of
central importance to leukemic myelomonocytic transformation.
C/EBPα controls the transition from common myeloid progenitors
to GMPs and prevents exhaustion of the HSC compartment (Zhang
et al, 2004). C/EBPα-deficient progenitors resist transformation by
MLL-ENL, MLL-AF9, MOZ-TIF2, and Hoxa9/Meis1. Interestingly, after
the establishment of MLL-ENL transformation, C/EBPα can be re-
moved genetically, whereas the malignant phenotype persists
(Ohlsson et al, 2014). These findings suggest that, in the presence of
C/EBPα, a “hit-and-run”–type MLL transformation consolidates an
epigenetic state that is maintained in the absence of the initial
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inducing transcription factor C/EBPα (Roe & Vakoc, 2014). Alter-
natively, other C/EBP family members that have not been examined
or that have remained undetected may be involved in maintaining
the myelomonocytic and transformed state.
Here, we considered the role of C/EBPβ in maintaining the
myeloproliferative MLL-ENL–transformed state. Using a somatic
genetics approach, we show that the viability and proliferation
of MLL-ENL–transformed mouse myeloblasts were impaired by
removing C/EBPβ and were almost entirely abrogated by com-
pound deletion of the Cebpa and Cebpb genes. Strikingly, all of
the few surviving Cebpa/Cebpb–deficient MLL-ENL–transformed
clones consistently expressed C/EBPε. Our data suggest that both
the initiation and the maintenance of MLL-ENL transformation
depend on transcription factors of the C/EBP family and imply a
therapeutic opportunity in interfering with the C/EBP dependency of
MLL transformation.
Results
Removing C/EBPβ slows the growth ofMLL-ENL–transformed cells
Experimentally induced murine leukemogenesis and acquisition of
the LSC state by the MLL-ENL, MLL-AF9, and MOZ-TIF2 oncogenes
depend on C/EBPα that induces myeloid commitment, or in the
absence of C/EBPα, on the alternative establishment of the GMP
state (Ye et al, 2015). This suggests that establishment of the GMP
phenotype is sufficient and subsequently epigenetically memo-
rized, in concordance with transformation by MLL-ENL. However,
the alternative induction of the GMP state in the absence of C/EBPα
requires C/EBPβ (Hirai et al, 2006; Manz & Boettcher, 2014). This
raises the possibility that C/EBPβ may be involved in maintaining
the LSC state and the leukemic process.
To distinguish between these possibilities, murine fetal liver
cells derived from conditional Cebpbfl/fl or Cebpafl/fl/Cebpbfl/fl
(designated WTFL) mice were retrovirally transformed by the MLL-
ENL oncogene, as outlined in Fig 1A. Briefly, MLL-ENL–transduced
liver cells were seeded in methylcellulose medium containing
cytokines (IL-3, IL-6, and stem cell factor [SCF]), and the emerging
transformed colonies were isolated after 10–14 d and expanded in
cytokine-supplemented liquid medium. MLL-ENL transformation
was evident by the stable growth of immortalized cells that could be
propagated in the presence of IL-3. Cytofluorometric analysis
showed that themajority of cells expressedmyeloid lineage surface
antigens (CD16/32 and CD11b), and that >25% of the transformed
populations also expressed c-Kit, a marker of HSC and early pro-
genitor cells (Fig S1A), suggesting a progenitor/GMP-type phenotype,
in agreement with published data (Somervaille & Cleary, 2006). After
myeloid cell transformation had been completed, MLL-ENL clones were
treated with cell membrane-permeable recombinant TAT-Cre (Brown &
Byersdorfer, 2017) to determine the biological effect of Cebpb
gene deletion on transformation (Fig S1B). Fig 1B and C show that
removing Cebpb from theMLL-ENL–transformed progenitors had
Figure 1. Cebpb Deletion in MLL-ENL–Transformed
Cells.
(A) Schematic illustration of murine tissue cultureMLL-
ENL leukemia model. Top to bottom: Murine fetal liver
cells from WTFL animals were transduced with MLL-
ENL and selected with G418 for 14 d in liquid culture.
Subsequently, the cells were seeded in semi-solid
methylcellulose medium. Single colonies were
isolated, expanded in liquid culture, and assessed for
MLL-ENL integration. Next, the cells were treated with
TAT-Cre recombinase to remove floxed Cebp alleles.
Gene excision was determined by PCR (see Fig S1B).
(B) Top: representative microscopic scans of semi-solid
methylcellulose cultures with WTFL and Cebpb KO
colonies. Cells were seeded at a density of 5,000 cells
per 35-mm well, and colonies were scored after 10 d.
Bottom: colony size distribution (see also Fig S1C).
(C) Top: WTFL and Cebpb KO colonies in semi-solid
methylcellulose medium. Middle: Growth curves of WTFL
and Cebpb KO colonies. Bottom: WST-1 assay showing
the effect of Cebpb removal on MLL-ENL–transformed
cells. Values are the mean ± SD (two-tailed
Mann–Whitney U test, **P < 0.005).
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little effect on total colony numbers; however, the secondary col-
onies derived from MLL-ENL C/EBPβ KO cells were smaller than the
colonies derived fromMLL-ENL cells with an intact Cebpb allele (Figs
1B and S1C). Cells derived from Cebpb KO cells showed decreased
growth rates and diminished metabolism and viability in culture
medium containing IL-3 (Fig 1C, cell counts and WST-1 to formazan
conversion) as compared with the wild-typeWTFLMLL-ENL–transformed
cells, in accordance with attenuated growth in semi-solid and liquid
cultures. We conclude that, although Cebpb is not essential for the
clonogenicity of MLL-ENL–transformed cells, it enhances their pro-
liferation and viability.
Simultaneous deletion of Cebpa/Cebpb inhibits
MLL-ENL–transformed cell proliferation
To generate compound Cebpa/Cebpb KO cells, two parental Ceb-
pafl/fl/Cebpbfl/fl MLL-ENL clones were infected with a retrovirus
encoding a conditional Cre recombinase, and Cebp allele deletion
was monitored by PCR. Cre-mediated gene deletion was readily
observed; however, even after prolonged Cre recombinase acti-
vation over 5 d, we failed to delete all four Cebp alleles over
numerous attempts (data not shown). In an alternative approach,
four parental Cebpafl/fl/Cebpbfl/fl MLL-ENL clones were treated
with recombinant TAT-Cre, which also resulted in allelic Cebp het-
erozygosity (Brown & Byersdorfer, 2017). Clones with partial Cebp
deletions were then pooled, expanded in mass culture (to ~4 × 106
cells), and re-treated with cell-permeable TAT-Cre recombinase to
force deletion of the remaining Cebpa/Cebpb alleles. The final round
of Cre treatment resulted in a widespread crisis of cell growth and
cell death. All surviving cells were directly seeded in semi-solid
medium for scoring potential Cebpa/Cebpb double KO (dKO) on a
clonal basis. In total, 1,056 colonies (from ~1,200 to 1,300 colonies)
were isolated and examined for Cebpa/Cebpb deletion. Only 14
Cebpa/Cebpb dKO subclones from two mice (2 and 12 subclones,
respectively) could be identified, suggesting that the transformed
MLL-ENL cells were strongly dependent on Cebpa/Cebpb gene
expression.
We next performed phenotypical analysis of WTFL, Cebpb KO, and
Cebpa/Cebpb dKO cells by flow cytometry (Fig 2). We detected no
differences in the frequencies of CD11b+ or Ly6C+ cells between the
WTFL and Cebpb KO cells, suggesting that the deletion of Cebpb was
compatible with maintaining the progenitor phenotype. Cebpb KO
cells, however, showed diminished development of mature Ly6G+
neutrophils, whereas differentiation into CD115+ monocytes or
macrophages in vitro was unaffected (Fig 2A). In contrast, com-
pound deletion of Cebpa and Cebpb led to reduced CD11b and Ly6C
reactivity, indicating a more immature or neomorphic phenotype
(Fig 2A). Accordingly, neither Ly6G+neutrophils nor CD115+monocytes
or macrophages could be derived from the Cebpa/Cebpb dKO cells
(Fig 2A). Analysis of the early and late apoptotic stages in the WTFL,
Cebpb KO, and Cebpa/Cebpb dKO clones showed that deleting
Cebpb and Cebpa/Cebpb partially and severely enhanced the
apoptosis rate, respectively (Fig 2A, right). Next, we analyzed the cell
proliferation rate by fluorescent CFSE dye dilution using flow cytom-
etry. As shown in Fig 2B, cells from all genotypes were characterized by
high proliferation rates. However, both single Cebpb and compound
Cebpa/Cebpb dKO cells showed reduced proliferation as compared
with the WTFL cells.
Histological staining of cytospins of WTFL, Cebpb KO, and Cebpa/
Cebpb dKO cells are shown in Fig 2C. WTFL cells characteristically
exhibited a predominant monoblastic/myeloblastic appearance,
sometimes with kidney-shaped nuclei, relatively pale cytoplasm,
and few, mostly diffuse cytoplasmatic granules. Cebpb KO cells
displayed a similar cytoplasm/nucleus ratio to WTFL cells, with early
monocytic/myelocytic appearance, some vacuoles, and most typ-
ically, azurophilic granules in the cytoplasm. The Cebpa/Cebpb dKO
cells had a smaller cytoplasm/nucleus ratio, with more darkly
stained cytoplasm and frequently hyposegmented nuclei. These
data suggest that the different genotypes are also reflected in
distinct early myelomonocytic phenotypes.
Comparative serial replating of the WTFL, Cebpb KO, and Cebpa/
Cebpb dKO cells revealed a steady increase in the clonogenicity of
the WTFL and Cebpb KO cells and a decline in that of the Cebpa/
Cebpb dKO cells (Fig 2D), suggesting enrichment for transformed
stem cells in the WTFL and Cebpb KO cells and the loss of stemness
in the Cebpa/Cebpb dKO cells during replating. The characteristic
heterogeneous appearance of the compact and disperse WTFL
colonies andmore uniform, round, and compact Cebpb KO colonies
was maintained during replating, whereas Cebpa/Cebpb dKO col-
onies continuously declined during replating and ceased growth
beyond the fourth replating (Fig 2E). However, differences in the
colony-forming capacity between the WTFL and Cebpb KO cells
became evident after partial withdrawal of cytokines (Fig 2F, growth
in IL-3 medium), revealing that the Cebpb KO cells were more
dependent on the standard cytokine mix (IL-3, SCF, IL-6, and GM-
CSF) than the WTFL cells.
Endogenous C/EBPε compensates for C/EBPα and C/EBPβ
deficiency in MLL-ENL–transformed cells
Related gene products may functionally compensate for distinct
deleted genes, and obscure otherwise severe phenotypes. In
particular, this can be observed in gene families that share evo-
lutionarily conserved origins, such as the C/EBP family (El-Brolosy
& Stainier, 2017). Therefore, we wondered about the compensatory
mechanisms that may have occurred in the Cebpa/Cebpb dKOMLL-
ENL clones to permit their survival. RNA sequencing (RNA-seq)
analysis of two randomly chosen dKO clones derived from dif-
ferent animals confirmed the absence of Cebpa and Cebpb ex-
pression (Fig 3A). Strikingly, both dKO MLL-ENL–transformed clones
showed up-regulated Cebpe gene expression, whereas Cebpd ex-
pression remained largely unchanged in the WTFL and dKO cells.
These data suggest that the activation of Cebpe may compensate
for the loss of Cebpa/Cebpb. Accordingly, we examined all 14 re-
covered dKO clones for expression of the C/EBP family members by
protein blotting. Fig 3B shows that all dKO clones strongly
expressed the C/EBPε protein, whereas only small and inconsistent
changes were observed in C/EBPδ, C/EBPγ, and C/EBPζ protein
levels. These data are in line with previous findings showing that
ectopic expression of C/EBPε, similarly to C/EBPβ but unlike
C/EBPα, is compatible with the proliferation of GMP-like progeni-
tors (Cirovic et al, 2017).
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All 14 recovered Cebpa/Cebpb dKO clones grew slowly in
liquid culture and had increased apoptosis, as compared with
the WTFL MLL-ENL–transformed cells (compare with Fig 2A, right),
suggesting incomplete functional compensation by C/EBPε. To
determine whether distinct C/EBP isoforms could rescue MLL-
ENL–transformed cell growth, isoforms of C/EBPα (p42 and p30) or
C/EBPβ (LAP*, LAP, and LIP) were retrovirally transferred and sub-
sequently enriched for co-expression of GFP, as shown in Fig 4A. As
expected, growing cells that expressed the proliferation-suppressive
C/EBPα p42 isoform could not be recovered, and the few GFP+ sorted
cells that grew out failed to express the p42 protein, confirming
successful retroviral transduction but failure of genetic com-
plementation by C/EBPα p42. Growing cells were obtained for all
other constructs (Fig 4A), and their proliferation rates, clonoge-
nicity, and viability were assessed. Colony formation of the pa-
rental dKO cells was partially rescued by the C/EBPα p30 isoform
(Fig 4B–D), and to a higher extent by the C/EBPβ LAP* isoform,
whereas the C/EBPβ LAP and C/EBPβ LIP isoforms displayed in-
termediate and no discernible complementation capacity, re-
spectively (Figs 4E–G and S2). In summary, the C/EBPβ LAP* isoform,
and in part, the C/EBPβ LAP or C/EBPα p30 isoforms, restored dKO
MLL-ENL–transformed cell proliferation (Fig 4B and E) and viability
(Fig 4C and F).
Next, we examined the role of C/EBPε in Cebpa/Cebpb dKO MLL-
ENL cells that expressed high levels of endogenous C/EBPε, termed
C/EBPε+, by RNA interference strategies. However, the fragile dKO
MLL-ENL C/EBPε+ cells did not tolerate the small interfering RNA
treatment, and various conditionally inducible, retrovirally deliv-
ered short hairpin RNAs failed to down-regulate C/EBPε repro-
ducibly (data not shown). The data may suggest that triple deletion
of the Cebpa, Cebpb, and Cebpe genes is incompatible with cell
survival. Interestingly, we observed that expression of the en-
dogenous C/EBPε ceased after extended cultivation of MLL-ENL
dKO cells that were complemented with the C/EBPβ isoforms LAP*,
Figure 2. Characterization and comparison of MLL-
ENL–transformed WTFL, C/EBPβ KO, and C/EBPα/C/
EBPβ dKO cells.
(A) Flow cytometric phenotyping of WTFL, Cebpb KO, and
Cebpa/Cebpb dKO cells using CD11b, Ly6C, CD117,
CD115, and Ly6G markers (left panel). Apoptosis was
examined via annexin V staining in combination with
7-AAD (right panel). Two independent experiments
were performed, yielding similar results. (B) Analysis of
frequency of cell division using CFSE in flow cytometry.
Cell types as in A and cells were analyzed 1, 3, and 4 d
after CFSE loading. Two independent experiments were
performed, yielding similar results. (C) Cytospins were
prepared from exponentially growing cell types and
stained with Giemsa/eosin. Micrographs were taken
from small groups of cells (left) to show uniformity and
from enlarged single cells (right) to show differences
in subcellular features. (D) Serial replating in
methylcellulose/Iscove’s DMEM supplemented with
IL-3, stem cell factor, GM-CSF, and IL-6. Cells were
seeded in triplicate, grown for 7 d, and colonies were
counted before reseeding at 5,000 cells/well. Two
independent experiments and for third and fourth
replating three experiments were performed, yielding
similar results. (E) Micrographs of colonies from fourth
replating. (F) Cells from the third replating round
were seeded in semi-solid medium supplemented with
the complete cytokine cocktail or IL-3 only, as indicated.
Colonies were counted after 7 d. Three independent
experiments were performed, yielding similar results.
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and to a lesser extent with LAP, but not with LIP (Fig 5A). Based on
the observation of an inverse correlation between resident C/EBPε+
protein levels before and after ectopic C/EBPβ LAP* expression (Fig
5A), we explored the mutability of Cebpe in dKOMLL-ENL cells in the
presence or absence of ectopically expressed C/EBPβ LAP*, as
outlined in Fig 5B. Briefly, targeted deletion of resident Cebpe by
Cas9 was examined after transduction of dKO cells with either
empty control or C/EBPβ LAP* retrovirus in parallel, both expressing
GFP as a marker. GFP+ cells from both approaches were sorted,
expanded, and infected with the same batch of a genome editing
vector, encoding blue fluorescent protein (BFP) as a marker and
Cas9 plus guide RNAs (Li et al, 2016; Henriksson et al, 2019), targeting
Cebpe exon 1. After infection, sorted BFP+ cells were expanded,
seeded in semi-solid medium, and individual colonies were iso-
lated from both vector control and C/EBPβ LAP* expressing cells
(Fig 5B).
In comparison to vector control cultures that showed many
abortive small colonies, augmented colony formation and prolif-
eration were already discernible at an early stage during colony
formation in C/EBPβ LAP*-complemented dKO cells (data not
shown). After single colonies had been isolated, proliferation in
liquid culture was discontinued in 35.9% of the vector control
clones (N = 79/220 clones), but only 17.8% (N = 32/180 clones) of the
C/EBPβ LAP* supplemented dKO clones were abortive (Fig 5C). Only
12.3% (27/220) of the vector controls, yet 48.9% (88/180) of the
C/EBPβ-LAP* dKO clones showed robust growth in liquid culture.
Among the vector control clones, all 27 properly growing control
clone isolates and 31 (out of 88) randomly chosen C/EBPβ LAP*-
complemented clones were expanded in liquid culture. As shown
by protein blotting (Fig 5D), each of the five LAP*-dKO and five vector
controls showed reciprocal expression of LAP* and C/EBPε. Analysis
of the genomic Cebpe status (Fig 5E) showed that 80% (16/27 clones)
Figure 3. MLL-ENL–Transformed dKO Clones Express
C/EBPε.
(A) Data showing normalized RNA-seq read counts
for indicated genes of the Cebp family in WTFL (gray)
and two independent Cebpa/Cebpb dKO MLL-
ENL–transformed cell clones (red) derived from
different mice. RNA-seq was performed in triplicates.
(B) Immunoblots show the expression of resident C/
EBP family proteins from WTFL and dKO transformed
MLL-ENL cells. The panel summarizes C/EBP family
protein expression in all 14 dKO clones from two
different mice (clone #1–12, mouse 1; clone #13 and #14,
mouse 2).
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of the vector control clones retained the WT Cebpe genotype, and
only two showed indel frameshift mutations (see below). In con-
trast, 74% (20/31 clones) of the C/EBPβ LAP*–complemented clones
showed biallelic frameshift indels and/or large deletions. Impor-
tantly, 7/27 vector control clones but only 2/31 of LAP* clones had
in-frame mutations. Both C/EBPβ LAP*–complemented in-frame
mutations were associated with frameshift indels in the second
Cebpe allele, whereas both frameshift indels of the vector control
cells retained either a WT or an in-frame deletion in the second
allele, respectively. Most remarkably, all in-frame mutations af-
fected negative regulatory C/EBPε regions I or II (Fig 5F), previously
described to restrain C/EBPε activity (Angerer et al, 1999). Taken
together, these data show that biallelic Cebpe inactivation in dKO
cells occurred only in the presence of C/EBPβ LAP*, but not in its
absence. In the absence of ectopically expressed C/EBPβ LAP*,
either the WT genotype persisted, or alternatively, in-frame dele-
tions affecting negative regulatory C/EBPε regions were selected,
strongly supporting the requirement of functional C/EBPε in the
absence of Cebpa/Cebpb. Accordingly, we conclude that myelo-
monocytic MLL-ENL transformation remains dependent on C/EBP
and that C/EBPε may partially compensate for the loss of Cebpa/
Cebpb.
C/EBPs coordinate the expression of the MLL-ENL/Hoxa target
genes
The combined deletion of Cebpa and Cebpb led to widespread
leukemic cell death and selected for compensatory expression of
C/EBPε in dKO clones, suggesting that maintenance of the trans-
formed cell identity is C/EBP-dependent. To test this hypothesis, we
performed RNA-seq (two clones, #5, #13, in triplicates) of the MLL-
ENL–transformed cell transcriptomes before and after compound
Cebpa/Cebpb deletion. Deleting Cebpa/Cebpb resulted in the
up-regulation of 2066 (clone #5) and 2,517 (clone #13) genes (755
genes overlapping), respectively, and the down-regulation of 2,447
(clone #5) and 2,702 (clone #13) genes (1,024 genes overlapping),
Figure 4. Complementation of Growth Defects by C/EBPα and C/EBPβ Isoforms
in MLL-ENL–Transformed dKO Cells.
(A) Transcripts of Cebpa and Cebpb with alternative translation initiation sites
(arrowheads; cyan) giving rise to different protein isoforms (indicated
underneath, purple, and on the right) as examined in Fig 4B. Below: C/EBP
expression controls of retrovirally expressed FLAG-tagged C/EBP isoforms
expressed in MLL-ENL–transformed dKO cells. Cell lysate immunoblots (IB) were
probed with anti-FLAG. GFP: negative control retrovirus; C/EBPα isoforms p42,
p30; C/EBPβ isoforms LAP*, LAP, and LIP. (B, C, D) C/EBPα complementation: (B, C,
D). (E, F, G) C/EBPβ complementation: (E, F, G). (B, C, D, E, F, G) Left, bottom insert:
Color code of complementation assays, as shown in (B, C, D, E, F, G). (B)Number of
MLL-ENL–transformed colonies derived from WTFL or dKO cells with and without
complementation by retrovirally encoded Cebpap30. Cells were seeded at 500 cells
per 35-mm well. The significance of the change in colony number between the
dKO and other groups was evaluated with the Kruskal–Wallis test, followed by the
post hoc Dunn test. (C) Growth curves of WTFL, dKO, and dKO cells complemented
with p30 C/EBPα. (D)WST-1 assay of WTFL, dKO, and dKO cells complemented with
p30 C/EBPα. Values are themean ± SD. The significance of the change inmetabolism
level between the dKO and other groupswas evaluatedwith the Kruskal–Wallis test,
followed by the post hoc Dunn test. (B, C, D, E) Colony formation ofMLL-ENL cells
as in (B, C, D). Panel shows the number of MLL-ENL–transformed colonies formed in
methylcellulose medium by WTFL, dKO, and complementation by retrovirally
encoded C/EBPβ LAP*, LAP, and LIP isoforms. Cells were seeded at 500 cells per
35-mm well. The significance of the change in colony number between the dKO and
other groups was evaluated with the Kruskal–Wallis test, followed by the post hoc
Dunn test. (F) Growth curves ofMLL-ENL–transformed WTFL, dKO, and LAP*-, LAP-,
LIP-C/EBPβ complementation dKO cells. (G) WST-1 assay of MLL-ENL–transformed
WTFL, dKO, and LAP*-, LAP-, and LIP-C/EBPβ complementation dKO cells. Values are
the mean ± SD. The significance of the change in metabolism level between the
dKO and other groups was evaluated with the Kruskal–Wallis test, followed by the
post hoc Dunn test.
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respectively, when a corrected P-value < 0.05 was used as the cutoff
(Fig 6A and Table S1).
We first investigated the impact of the combined loss of C/EBPα
and C/EBPβ on the direct and indirect targets of MLL-ENL (Collins
et al, 2014; Garcia-Cuellar et al, 2016). Of the 166 direct/coreMLL-ENL
target genes, a significant 70 genes (P = 2.97 × 10−12) were among the
deregulated genes. Interestingly, 61 of these 70 genes had absolute
fold change (FC) < 2, including Hoxa10 and Hoxa9 (P = 0.07) (Fig 6B).
As many of the MLL-ENL target genes were significantly but not
highly deregulated, we presumed that the high levels of surrogate
C/EBPε stabilized the expression of the core MLL-ENL target genes
in C/EBPε+ dKO. Other, more dysregulatedMLL-ENL candidates (FC > 2;
P < 0.05) were the DOT1L/transcription initiation–sensitive genes
Bahcc1 and Fut8, and the Brd4/elongation-sensitive genes Sox4
and Mpo, which were all up-regulated, suggesting that they were
partially repressed by C/EBPβ and/or C/EBPα (as already known for
C/EBPα-mediated Sox4 suppression [Zhang et al, 2013]). Otherwise,
C/EBPε may represent a less potent inhibitor or a more potent
activator of these genes (Zhang et al, 2013).
For the indirect MLL-ENL targets, removing C/EBPα and C/EBPβ
affected the genes downstream of the transcriptional control of
HOXA9/MEIS1 that had been identified after the removal of Cebpa in
HOXA9/MEIS1–transformed cells (Collins et al, 2014; Collins & Hess,
2016a, 2016b). Gene set enrichment analysis (GSEA) (Liberzon et al,
2011; Wu & Smyth, 2012) revealed significantly deregulated HOXA9-
mediated gene suppression (P < 0.05) (Fig 6C), including Cpa3, Gzmb,
Peg13, Mycn, Hgfac, Alox5, Gata2, Nkg7, Stx3, Cdh17, Scin, Rgs10,
Havcr2, and Col18a1, but excluding the self-renewal inhibitor
Cdkn2b (gene set extracted from Collins et al [2014]). The entire
HOXA9/C/EBPα co-activated gene set was not significantly deregu-
lated, yet the dKO cells showed increased Adra2a, Pcp4l1, Itsn1,
and Igf2r expression from the HOXA9/C/EBPα co-activated set,
whereas Adam17, Gm1110, Pde7a, Pdcd4, and Nrg2 expression were
reduced.
Next, we investigated lineage restriction in the transformed cells
by comparing the transcriptional landscape of WTFL and dKO cells
to the ImmGen database (Heng & Painter, 2008). Compared with the
WTFL cells, the dKO cells lost some of their myeloid expression
Figure 5. Examination of C/EBPε dependency of MLL-
ENL–transformed Cebpa/Cebpb dKO C/EBPε+ cells
via genome editing.
(A) C/EBPε protein levels after prolonged growth of WTFL
and dKO cells infected with control virus (GFP) or
vectors encoding different C/EBPβ isoforms. (B)
Scheme of Cas9-mediated genome editing. C/EBPε+ dKO
cells were infected with control virus or C/EBPβ LAP*-
encoding virus, both expressing GFP. After infection,
cells were grown for 3 d, sorted by flow cytometry, and
GFP+ cells were expanded for 9 d. C/EBPε+ dKO vector
control cells and C/EBPβ LAP*-complemented cells
were infected with retrovirus encoding BFP, Cas9, and
guide RNAs targeting Cebpe exon 1. After 3 d, the cells
were sorted and expanded for 6 d, and seeded in semi-
solid medium containing IL-3. Individual colonies were
isolated and expanded in 96-well plates in liquid
medium (plus IL-3). (C) Growth of isolated cells from
single colonies was microscopically inspected over 1 wk
and scored as fast, slow, or abortive growth.
(D) Randomly chosen fast-growing clones from (D)
were examined by protein blotting for expression of C/
EBPε and C/EBPβ, and GAPDH as the loading control
by protein-specific antibodies, as indicated on the left.
(E) Cebpe exon 1 DNA derived from 27 vector control
clones and 31 C/EBPβ LAP*-complemented clones
was amplified by PCR and analyzed by Sanger
sequencing and the Inference of CRISPR Edits (ICE)
software tool (ice.synthego.com). (F) (Middle) Scaled
schematic representation of C/EBPε showing the
transactivation (TAD), regulatory (RD1 and RD2), and
basic zipper (bZIP) regions. Top: examples of in-frame
deletions in RD1 from two vector control clones (clones
#49 and #56). Bottom: examples of in-frame deletions in
RD2 (vector control clone #12) and one LAP*-
complemented clone (#4) with an in-frame deletion in
one C/EBPε allele and frameshift in the second allele.
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Figure 6. Molecular Genetic Profiling of MLL-ENL–Transformed dKO Cells.
(A) Venn diagrams showing the overlap between up-regulated (Benjamini–Hochberg corrected P-value < 0.05) and down-regulated (Benjamini–Hochberg corrected P-
value < 0.05) genes in both dKO clones as determined by RNA-seq. N = 3 per genotype. (B) Scatter plot showing dysregulation of MLL-ENL target genes, which are colored
according to P-value and fold change. All remaining genes are colored according to their P-value only (see figure key). Two genes, Igf1 and Bcl11a, are included in the plot,
as they are known MLL translocation targets. (C) Gene set enrichment analysis showing significant enrichment of genes co-repressed by HOXA9/C/EBPα among the
deregulated genes. Most of these genes were up-regulated in the dKO cells. (D) Comparison of expression patterns to that of ImmGen data shows a shift in overall gene
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characteristics and showed less similarity to monocytes and
macrophages (Fig 6D). Specifically, Csf1r, Rel family members (Rel,
Rela, and Relb), and Tgfbr2 levels were decreased in the dKO cells,
supporting the pioneering role of C/EBPα and C/EBPβ in myeloid
commitment (Wang et al, 2006; Jaitin et al, 2016; Tamura et al, 2017).
However, the WTFL and dKO cells were similarly enriched for genes
shared with HSC, highlighting the LSC state of the cells.
For a more general/unbiased approach, we performed GSEA on the
hallmark gene sets of MsigDB to examine the enrichment of functional
terms in the group of differentially expressed genes between the WTFL
and dKO genotypes (Liberzon et al, 2011; Wu & Smyth, 2012). Consistent
with the reduced myeloid commitment observed in the dKO cells (Fig
2A), we detected strong dysregulation of the inflammatory genes,
documented by significant enrichment of “hallmark inflammatory
response” and “hallmark Tnfa signaling via Nfkb” (P < 0.05) with
partially overlapping genes, in addition to an increase in stem cell
transcripts (see the corresponding heat maps in Fig 6E). Altogether,
these results support the premise that C/EBPε partially compensates
for the loss of Cebpa/Cebpb by securing a MLL-ENL and Hoxa9 reg-
ulated core gene expression program and shifts the transformed
phenotype towards an immature phenotype.
The superior growth and viability of the WTFL and dKO-LAP* cells
over Cebpa/Cebpb dKO cells was evident, affirming that compen-
sation by C/EBPε remains incomplete. To identify ancillaryMLL-ENL
targets that may be involved in restoring the WT phenotype, we
compared differential gene expression with the genome accessi-
bility status using Assay for Transposase-Accessible Chromatin with
sequencing (ATAC-seq) (Buenrostro et al, 2013) in the three ge-
notypes, that is, WTFL, Cebpa/Cebpb dKO, and Cebpa/Cebpb dKO
complemented with C/EBPβ LAP*. Initial inspection of chromatin
accessibility around the Cebpa/Cebpb loci confirmed the dKO
status, whereas the ATAC peak pattern around the Cebpe locus
remained unchanged, ruling out the possibility that a recombi-
nation event at the Cebpe locus may have contributed to enhanced
Cebpe expression in the dKO cells (Fig 6H). Focusing on genes that
exhibited both, re-establishing gene expression and restoring
chromatin status in dKO-LAP* cells towards WTFL status yielded a
list of genes (highly correlated gene expression and chromatin
status), part of which is shown in Fig 6F. Importantly, known motif
search showed significant enrichment of the CEBP, ETS, and RUNX
binding motifs (Fig 6G) in the genomic regions determined by the
full list of ATAC peaks, as described in Fig 6F. Fig 6H shows that, in
dKO cells, the enhanced Sox4 and Ikzf2 gene expression (Fig 6B) was
associated with increased chromatin accessibility, whereas de-
creased Bcl11a and Igf1 gene expression was associated with
decreased ATAC peak sizes, whereas ectopic expression of LAP*
restored ATAC peaks to the WT conditions (Fig 6H).
Open chromatin regions that were present in WTFL cells, absent
in dKO cells, and restored in dKO-LAP* cells were identified in an
intronic region of the Igf1 gene (Fig 6H) that overlapped with a
super-enhancer region previously identified in monocytes and liver
cells (Jiang et al, 2019). Moreover, IGF1 has been described as a
growth-regulatory MLL-ENL/Hoxa9/Meis1 target and as a direct
C/EBPβ target gene involved in autocrine stimulation of trans-
formed murine monocytes and in neoplasia (Pollak et al, 2004;
Wessells et al, 2004; Steger et al, 2015; Collins & Hess, 2016b).
Comparison of the Igf1 RNA-seq reads confirmed Igf1 gene ex-
pression in theWTFL and dKO-LAP* cells, but not in the dKO cells (Fig
6I, top panel), and quantification by ELISA in tissue culture
supernatants (Fig 6I, bottom panel) showed that IGF1 was produced
by theWTFL and dKO-LAP* cells, but not by dKO cells. Adding IGF1 (10
ng/ml) to the culture medium increased the cell number, viability
(toluidine exclusion), and metabolism (WST-1 conversion) of the
dKO culture (Fig 6J) but not that of the WTFL or dKO-LAP* cultures
(Fig 6K). Taken together, these data suggest that C/EBP family
member- and isoform-specific regulation can differentially affect
several MLL-ENL target genes. The data also confirm a C/EBPβ co-
regulated autocrine function of IGF1 in MLL-ENL transformation.
Discussion
Myelomonocytic commitment and differentiation into the GMP
state depends on C/EBP transcription factors and is a prerequisite
for the emergence of AML and LSC. Our data show that the con-
tinuous presence of C/EBP transcription factors is essential for
maintaining leukemic myelomonocytic transformation by the MLL–
ENL oncogene product of fetal liver hematopoietic progenitor cells
in tissue culture.
A current concept of myeloid leukemogenesis suggests that LSC
arise in committed progenitors that resemble GMP-like cells that
acquire self-renewal capacity (Cozzio et al, 2003; Huntly et al, 2004;
Jamieson et al, 2004; Krivtsov et al, 2006). As an inducer of the GMP-
like state, it has been suggested that C/EBPα plays a critical role in
leukemic myelomonocytic transformation. Intriguingly, once leu-
kemic progenitor transformation is established, C/EBPα can be
genetically removed, whereas the leukemic state persists (Ohlsson
et al, 2014; Ye et al, 2015). Along the same lines, the initiation of
oncogene-induced leukemic transformation in the absence of C/EBPα
expression patterns, with loss of myeloid characteristics and maintenance of stem cell patterns in dKO cells indicated by Spearman correlation. (E) Heatmap of
inflammatory and TNFα/NF-κB hallmark genes (gene sets derived from MSigDB) in WTFL and dKO cells. Both terms are significantly enriched (adjusted P-value < 0.05,
according to Gene set enrichment analysis). The heat maps show genes of the respective gene sets exhibiting an adjusted P-value < 0.05 and an absolute fold change > 2.
Row z-score of normalized log2 counts. (F) Subset of the co-regulated transcriptome and genome structure as determined by RNA-seq and ATAC-seq. The whole list
comprises genes that exhibit both the re-establishment of gene expression and restoration of the chromatin status in dKO-LAP* cells to WTFL status. Row z-score of
normalized log2 counts. (F, G) Knownmotif prevalence in dKO-LAP* cells in the full set of genes shown in (F) as determined by HOMER. (H) Examples of replicate ATAC-seq
data from WTFL, dKO, and dKO-LAP* MLL-ENL–transformed cells indicating gain of peaks (left, blue outline) in dKO at the Sox4 and Ikzf2 loci, and loss of peaks at the
Bcl11a and Igf1 loci (right, red outline). The top three lanes show C/EBPα and C/EBPβ chromatin immunoprecipitation (ChIP) data from MLL-AF9–transformed cells (Roe
et al, 2016); the bottom three lanes show Hoxa9 ChIP data from Zhong et al (2018). (I) Igf1 gene expression (top: RNA-seq data from triplicates) and IGF1 secretion into the
growthmedium (bottom: ELISA data; ELISA was repeated 3 times yielding similar results) byMLL-ENL–transformed cells. (J) Response ofMLL-ENL–transformed dKO cells
to the addition of IGF1 to the culturemedium as determined by cell counts, viability, andmetabolic activity. (K) Comparison of response to IGF1 of WTFL, dKO, and dKO-LAP*-
complemented cells.
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can still be achieved, if concomitant emergency granulopoiesis is
induced (Ye et al, 2015). These data suggest the achievement of the
GMP-like state as the most critical event in leukemic transformation,
regardless of how the GMP state is achieved. However, emergency
granulopoiesis elicits C/EBPβ expression (Hirai et al, 2006), and gene
replacement experiments have shown that C/EBPβ expressed from
the C/EBPα locus can fully complement the hematopoietic functions
of C/EBPα, including differentiation into GMP (Jones et al, 2002). The
alternative explanation for the maintenance of the leukemic state
after removing C/EBPα, therefore, is that C/EBPα may initially pass
the “GMP baton” to C/EBPβ, which in turn supports proliferation and
maintains the transformed myeloid state.
Our data show that maintaining myeloid MLL-ENL transforma-
tion strongly depends on combined C/EBPβ and C/EBPα expres-
sion. The non-oncogenic dependence (Solimini et al, 2007; Nagel
et al, 2016) on C/EBP transcription factors became evident from the
analysis of the dKO mutants, which yielded very few clonogenic
cells that consistently expressed resident C/EBPε. Genetic removal
of both Cebpa and Cebpb consequently revealed a surrogate
function of C/EBPε in myeloidMLL-ENL transformation. This finding
is in line with several KO studies involving various members of the
C/EBPα, β, δ, and ε family that revealed redundant C/EBP functions
only in compound deletion mutants. Indeed, C/EBPε partially
compensated for the loss of C/EBPβ during murine myelopoiesis
and the innate immune response and was also compatible with the
proliferative progenitor state (Akagi et al, 2010; Cirovic et al, 2017).
Whether the rare event of C/EBPε expression in the MLL-ENL–
transformed cultures may have occurred before or after Cebpa or
Cebpb deletion, potentially reflectingMLL-ENL progenitor plasticity,
or as a regulatory event that occurred under the selective pressure
of Cebpa/Cebpb removal, remains to be determined.
The data suggest a compensatory backup function of C/EBPε in
the surviving Cebpa/Cebpb dKO MLL-ENL cells that may maintain
the minimal essential GMP condition in the absence of Cebpa/
Cebpb and serve as a proxy in regulating the most critical genes
involved in MLL-ENL transformation. Consistently, genetic removal
of C/EBPε from dKO cells by gene editing was only possible after
complementation with C/EBPβ LAP*, whereas uncomplemented
cells only tolerated C/EBPε gene editing as in-framemutations that
removed parts of the negative regulatory regions of the C/EBPε
protein (Angerer et al, 1999). Taken together, the results suggest the
essential functions of C/EBP family members, and in particular, a
privileged function of C/EBPβ LAP* in the proliferation, survival, and
maintenance of the myeloid cell fate of transformed MLL-ENL cells.
Regulation of the Hox cluster target genes, including Hoxa9 and
Meis1, previously emerged as a hallmark of MLL translocation leuke-
mia, and the combined expression of Hoxa9 and Meis1 was suf-
ficient for initiating a leukemogenic progenitor self-renewal program
(Armstrong et al, 2002; Ayton & Cleary, 2003; Ferrando et al, 2003;
Huang et al, 2012; De Braekeleer et al, 2014; Garcia-Cuellar et al, 2016;
Collins & Hess, 2016a). C/EBPα is also essential in Hoxa9/Meis1-
induced leukemic transformation (Collins et al, 2014), yet HOXA9/
HOXA10/Meis1 were only partially down-regulated in the Cebpa/Cebpb
dKO C/EBPε+ cells. We believe that the expression of resident C/EBPε
in the dKO cells compensated further down-regulation beyond a
lower limit, thereby functionally substituting for the absence of
Cebpa/Cebpb, whereas cells that failed to express C/EBPεwere lost.
Accordingly, the most strongly affected genes in the dKO cells may
therefore represent secondary functional targets, such as autocrine IGF1
stimulation, which contributed to accelerated growth and prevention of
apoptosis, but may not be entirely central to leukemic transformation.
Previous research suggesting a C/EBPα-induced epigenetic state
that is subsequently maintained by the MLL-ENL oncoprotein
(Ohlsson et al, 2014; Roe & Vakoc, 2014) is contrasted by various
lines of evidence suggesting that, in higher organisms, mainte-
nance of the epigenetic state relies on the continuous presence of
priming master regulatory transcription factors (Blau et al, 1985;
Blau & Baltimore, 1991; Holmberg & Perlmann, 2012). Our data
support the latter concept and suggest a prominent role for distinct
C/EBP family members and isoforms in MLL-ENL transformation,
reflecting a type of lineage- and differentiation state–specific non-
oncogenic dependence on transformation. Pharmacological in-
terference with the non-oncogenic C/EBP dependence on acutely
transforming myelomonocytic oncoproteins could potentially ex-
tend a future clinical repertoire of treatment regimens with the aim
of eradicating devastating infant AML.
Materials and Methods
Generation of MLL-ENL–transformed cells
Viral supernatants were produced by transfecting Plat-E cells with pMIG-
GFP retroviral vector or pMSCV-MLL-ENL construct. Infectious supernatant
was collected 48 and 72 h post-transfection. Mouse embryos (13.5 d) were
dissected and genotyped. Hematopoietic stem and progenitor cells were
isolated from the mouse fetal livers and transduced during two con-
secutivedaysby centrifugation (twice: 1h, 900g)withviral supernatantand
8 μg/ml hexadimethrine bromide. After the second infection, the cells
were recovered in IMDM supplemented with murine IL-3 (10 ng/ml), IL-6
(10 ng/ml), and SCF (50 ng/ml) (STEMCELL Technologies). Infected cells
were selected with 500 μg/ml G418 (Sigma-Aldrich). After 14-d antibiotic
selection, the cells were seeded in MethoCult M3434 (STEMCELL Tech-
nologies). Colonies formed from single cells were isolated, expanded, and
analyzed. Flow cytometry was performedwith LSR II or Fortessamachines
(Becton Dickinson). The following antibodies from BioLegend or eBio-
science were used: CD11b (M1/70), CD117 (2B8), Ly6C (AL-21), Ly6G (1A8),
CD115 (AFS98), Sca1 (D7), and CD64 (X54-5/7.1).
Cell culture
The MLL-ENL–transformed cell lines were cultured in IMDM (10%
FCS, 1% penicillin/streptomycin [Gibco]) supplemented with 10 ng/
ml mouse IL-3 (STEMCELL Technologies). Cells were split every 2–3 d
to 1 × 105 cells/ml. Plat-E cells were cultured in DMEM (10% FCS, 1%
Hepes, and 1% penicillin/streptomycin [Gibco]). Transient trans-
fections were performed using polyethylenimine (Polysciences)
according to the manufacturer’s protocol.
TAT-Cre treatment and selection of recombinant clones
Before the treatment, TAT-Cre recombinase (Millipore) was di-
luted to a final concentration of 4 μM in IMDM and filtered (0.2-μm
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low-protein-binding filter). Cell pellets of 4 × 105MLL-ENL–transformed
cells were resuspended in 1ml TAT-Cre solution, transferred to a 24-well
plate, and incubated at 37°C for 20 h. The cells were washed with PBS
andseeded inMethoCultM3134 (STEMCELL Technologies) supplemented
with 10 ng/ml mouse IL-3. Colonies were transferred to liquid medium,
expanded, and analyzed by PCR for excision of Cebpa and/or Cebpb.
Retroviral transduction with C/EBP isoforms, GFP vector control,
or BFP Cas9-sgRNA C/EBPε
Viral supernatants were produced by transfecting Plat-E cells with
empty pMIG-GFP retroviral vector or pMIG-GFP constructs containing
p42, p30, LAP*, LAP, or LIP, or pMSCV-BFP constructs containing Cas9
and sgRNAs targeting Cebpe. The cells were centrifuged with infectious
supernatant collected 72hafter transfectionand8μg/mlhexadimethrine
bromide (1 h, 900g), and left for recovery overnight.
Plasmids and retroviral constructs
TheMLL-ENL retroviral construct has been described previously (Slany
et al, 1998). C/EBPα, β isoform expression constructs, amino acid
sequence, and retroviral construction have been published previously
and are available on request (Kowenz-Leutz et al, 1994; Stoilova et al,
2013; Cirovic et al, 2017). pMSCV_Cas9-2A-GFP-sgRNA (#124889; Addg-
ene) and pMSCV-U6sgRNA(BbsI)-PGKpuro2A-BFP (#102796; Addgene)
were purchased (Li et al, 2016; Henriksson et al, 2019). The T2A-GFP
fragment of the pMSCV GFP-Cas9–containing construct was excised by
BamHI/NotI restriction digest. The T2A-BFP marker of pMSCV-
U6sgRNA(BbsI)-PGKpuro2A-BFP was amplified by PCR and cloned
as aBamHI/NotI fragment into the pMSCV Cas9 construct. BFP primer:
59 BamHI_T2A-BFP 59-CGCGGATCCGGAGAGGGCAGAGGAAGTCTC-39; 59-
BFP-NotI: 59-ATAGTTTAGCGGCCGCTCAATTAAGCTTGTGCCC-39.
Cebpe sgRNAs were selected using CrispRGold (https://crisprgold.
mdc-berlin.de) and CRISPOR (http://crispor.tefor.net). The sgRNAs
were cloned by BbsI into the pMSCV_Cas9-2A-BFP-sgRNA vector. The
C/EBPε sgRNA oligos used were 59-CTTACCTTGAGGACACGCAA-39, 59-
AGGGATAGGCGAATGGCCGA-39, 59-CTCGTTTCCTCACTACCTGC-39, and 59-
CGCACTCATAGTAGGTCCCG-39.
Analysis of C/EBPε genome editing by CRISPR/Cas9 and C/EBPε
sgRNAs
Total DNA was isolated from single cell clones using Quick-
Extract DNA Extraction Solution (Epicentre). Cebpe genomic
exon 1 was amplified by PCR, the fragments were purified (Invisorb
#1020300300; Invitek), and analyzed by Sanger sequencing (LGC
Genomics). The edited sequences were analyzed using modified ICE
software (Hsiau et al, 2018 Preprint), available from Synthego
(https://www.synthego.com/products/bioinformatics/crispr-analysis).
The PCR primers used for Cebpe exon 1 analysis were 59-CAGGACA-
CAGCCGAGTTCTA-39 and 59-CTAGGGCAAATCTAGGACCG-39.
Genotyping
Total DNA was isolated using QuickExtract DNA Extraction Solution
(Epicentre). Cebpa excision was evaluated by two separate PCR for the
Cebpa flox allele and Cebpa deletion. The Cebpa flox allele primers
were 59-TGGCCTGGAGACGCAATGA-39 and 59-CGCAGAGATTGTGCGTCTTT-
39; the expected product was 269 bp. The Cebpa deletion primers were:
59-GCCTGGTAAGCCTAGCAATCCT-39 and 59-TGGAAACTTGGGTTGGGTGT-39;
the expected product was 380 bp. Cebpb excision was determined by
competitive PCR using the following primers: 59-GAGCCACCGCGTCCT-
CCAGC-39, 59-GGTCGGTGCGCGTCATTGCC-39, and 59-AGCAGAGCTGCCCC-
GGCAAA-39; the reaction produced bands of 253 bp for the flox allele
and 610 bp for the deleted allele.
Immunoblotting
Total protein lysates were prepared by lysing fresh cell pellets with
0.5 M NaOH with subsequent neutralization with 0.5 M HCl. The
samples were sonicated, mixed with SDS sample buffer and glyc-
erol, and heated (3 min at 95°C). After centrifugation, the protein
lysates were separated by electrophoresis and transferred to a ni-
trocellulose membrane using a Trans-Blot Turbo System (Bio-Rad).
Protein signals were detected after incubation with antibodies
against C/EBPα (14AA; Santa Cruz Biotechnology), C/EBPβ (C-19; Santa
Cruz Biotechnology), C/EBPδ (C-22; Santa Cruz Biotechnology), C/
EBPε (NBP1-85446; Novus Biologicals), Flag-M2 (F-1804; Sigma-Aldrich),
and GAPDH (ab9484; Abcam).
Apoptosis assay
The level of apoptosis was determined with a FITC–Annexin V
Apoptosis Detection Kit I (BD Pharmingen). After washing twice with
cold PBS, 1 × 106 cells were resuspended in 1 ml 1× binding buffer.
Cell suspension (100 μl) was transferred to a new tube and mixed
with 5 μl FITC–annexin V. The samples were incubated for 15 min at
room temperature in the dark. Afterward, 5 μl 7-AAD (BD Phar-
mingen) was added and the samples were subsequently analyzed
using an LSR II flow cytometer (Becton Dickinson).
Proliferation and metabolism assays
TheMLL-ENL–transformed cells were seeded at 5 × 104 cells per well
in 100 μl complete IMDM in 96-well plates in triplicate. The cells
were incubated for 48, 72, or 96 h at 37°C. The cell proliferation
reagent WST-1 (10 μl/well; Roche) was added, gently mixed, and
incubated at 37°C for 1 h. The absorbance of the samples was
measured at 450 nm using an iMark microplate reader (Bio-Rad). A
murine IGF-1 ELISA kit (BGK9PU89; BioGems) was applied according
to the manufacturer’s protocol. For the CFSE proliferation assay, 1 ×
106 cells were resuspended in 1 ml 5 μM CFSE solution (BioLegend)
for 20 min in the dark at room temperature. Afterward, the reaction
was quenched using 5 ml cell culture medium plus 10% FCS. The
cells were washed and cultured for the indicated time.
Colony formation assay, determination of colony size and
number, serial replating
The MLL-ENL–transformed cells were added to complete (10% FCS,
1% penicillin/streptomycin [Gibco]) and IL-3–supplemented (10 ng/
ml) MethoCult 3134 (STEMCELL Technologies) at a final concen-
tration of 5,000 cells per mL (if not indicated otherwise). The cell mix
(1 ml) was seeded in six-well meniscus-free plates (SmartDish;
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STEMCELL Technologies) in triplicate. High-resolution microscopic
scans were taken after 7, 10, and 14 d using an EVOS imaging system
(Thermo Fisher Scientific). The number, size, and approximate cell
numbers of the colonies were calculated using ImageJ software
with the ColonyArea plugin. Serial replating experiments were set
up with 5,000 cells permL inMethoCult 3134 supplemented with IL-3
(10 ng/ml), IL-6 (5 ng/ml), SCF (25 ng/ml) and GM-CSF (5 ng/ml).
After 7 d in culture, colony numbers were determined using the
EVOS imaging system, colonies were harvested by centrifugation in
culture medium, cell numbers and viability were determined, and
comparable numbers of cells were re-seeded in MethoCult 3134
under the conditions described above.
ATAC-seq
To prepare the ATAC-seq libraries, 50,000 cells were sorted into 500 μl
PBS. The libraries were prepared as previously described (Buenrostro
et al, 2013), with slightmodifications (Lara-Astiaso et al, 2014). Briefly, the
cells were lysed with 25 μl cold lysis buffer (10 mM Tris–HCl [pH 7.4], 10
mM MgCl2, and 0.1% Igepal CA-630) and the nuclei were pelleted by
centrifugation for 25 min at 4°C and 500g in a swing rotor with low
acceleration and brake settings. The pellet was resuspended in 25 μl
reaction mix containing 2 μl Tn5 transposase and 12.5 μl TD buffer
(Nextera DNA library preparation kit; Illumina), and incubated at 37°C for
1 h. Next, 5 μl cleanup buffer (900 mM NaCl, 30 mM EDTA) with 2 μl 5%
SDS and 2 μl proteinase K (NEB) were added, and the samples were
incubated at 40°C for 30 min. Subsequently, the DNA was purified using
AMPure XP beads (Beckman Coulter) and PCR-amplified with KAPA HiFi
HotStart ReadyMix (Kapa Biosystems) and indexing primers published
previously (Buenrostro et al, 2013). Then, the DNA library fragments were
selected for <600-bp fragments and purified using AMPure XP beads.
The concentration and fragment size of the final libraries were mea-
sured using a Qubit fluorometer (Life Technologies) and TapeStation
(Agilent Technologies). The samples were sequencedwith an average of
25 million reads per sample using a NextSeq 500 system (Illumina).
Sequencing data analysis
RNA-seq libraries were prepared using Illumina TruSeq stranded
mRNA kit starting with 500 ng of input total RNA. Libraries included
dual indices and were equimolar pooled. Paired-end 76 nt sequencing
was performed on Illumina NextSeq 500 High Output v.2 flowcell. RNA-
seq samples were aligned to the reference genome (mm10) using STAR
(Dobin et al, 2013). Expressionwas quantifiedusingHTSeq (Anders et al,
2015); downstream analysis was done with DESeq2 using the included
normalization strategy (for details see Love et al [2014]) and a
Benjamini–Hochberg–corrected P-value of 0.05 as a significance
cutoff. Alterations in function induced by the different expression
patterns in the conditions were assessed using GSEA using gene sets
by MSigDB (Liberzon et al, 2011) and Camera (Wu & Smyth, 2012). ATAC-
seq samples were preprocessed with PiGx pipelines (Wurmus et al,
2018), including alignment to a reference with Bowtie 2 (Langmead &
Salzberg, 2012), to genome version mm10 and peak-calling using MACS
(Zhang et al, 2008). Differential peaks were detected with DiffBind (2.14)
using a corrected P-value of 0.05 as a cutoff (Ross-Ines et al, 2012).
Known motif detection was performed using findMotifsGenome.pl in
HOMER (v4.10.3) ($ findMotifsGenome.pl XXX.bed mm10 homer/ -size
200 -mask) (Heinz et al, 2010). The set of genomic regions used formotif
discovery comprises the regions of those genes, that exhibited both,
re-established gene expression (uncorrected P-value < 0.05) and re-
stored chromatin status (corrected P-value < 0.05) in dKO-LAP* cells
toward the WTFL status.
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